REPORT ID 2860

China Bio-pharma Market Research Report 2017

Publish Date
11-Dec-17
Pages
109
Format
Electronic (PDF)

The global Bio-pharma market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

China plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%.

This report studies the Bio-pharma development status and future trend in China, focuses on top players in China, also splits Bio-pharma by type and by applications, to fully and deeply research and reveal the market general situation and future forecast.

The major players in China market include
    Pfizer
    F. Hoffmann-La Roche AG
    Johnson & Johnson Services
    Sanofi, Amgen
    AbbVie
    Merck & Co., Inc
    Biogen Idec
    Bayer AG
    Eli Lilly and Company
    Novartis AG GlaxoSmithKline Plc
    Bristol-Myers Squibb Company
    AstraZeneca PLC
    Abbott Laboratories

Geographically, this report splits the China market into six regions,
    South China
    East China
    Southwest China
    Northeast China
    North China
    Central China
    Northwest China

On the basis of product, this report displays the sales volume (K Pcs), revenue (Million USD), product price (USD/Pcs), market share and growth rate of each type, primarily split into
    Monoclonal Antibodies
    Recombinant Proteins
    Granulocyte-Colony Stimulating Factor (G-CSF)
    Interferons
    Recombinant Human Insulin
    Erythropoietin
    Vaccines
    Growth Hormones
    Purified Proteins
    Others

On the basis of the end users/application, this report covers
    Metabolic Disorders
    Oncology
    Neurological Disorders
    Cardiovascular Diseases
    Inflammatory and Infectious Diseases
    Others

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

China Bio-pharma Market Research Report 2017
1 Bio-pharma Overview
    1.1 Product Overview and Scope of Bio-pharma
    1.2 Classification of Bio-pharma by Product Category
        1.2.1 China Bio-pharma Sales (K Pcs) Comparison by Type (2012-2022)
        1.2.2 China Bio-pharma Sales (K Pcs) Market Share by Type in 2016
        1.2.3 Monoclonal Antibodies
        1.2.4 Recombinant Proteins
        1.2.5 Granulocyte-Colony Stimulating Factor (G-CSF)
        1.2.6 Interferons
        1.2.7 Recombinant Human Insulin
        1.2.8 Erythropoietin
        1.2.9 Vaccines
        1.2.10 Growth Hormones
        1.2.11 Purified Proteins
        1.2.12 Others
    1.3 China Bio-pharma Market by Application/End Users
        1.3.1 China Bio-pharma Sales (K Pcs) and Market Share Comparison by Applications (2012-2022)
        1.3.2 Metabolic Disorders
        1.3.3 Oncology
        1.3.4 Neurological Disorders
        1.3.5 Cardiovascular Diseases
        1.3.6 Inflammatory and Infectious Diseases
        1.3.7 Others
    1.4 China Bio-pharma Market by Region
        1.4.1 China Bio-pharma Market Size (Million USD) Comparison by Region (2012-2022)
        1.4.2 South China Bio-pharma Status and Prospect (2012-2022)
        1.4.3 East China Bio-pharma Status and Prospect (2012-2022)
        1.4.4 Southwest China Bio-pharma Status and Prospect (2012-2022)
        1.4.5 Northeast China Bio-pharma Status and Prospect (2012-2022)
        1.4.6 North China Bio-pharma Status and Prospect (2012-2022)
        1.4.7 Central China Bio-pharma Status and Prospect (2012-2022)
    1.5 China Market Size (Sales and Revenue) of Bio-pharma (2012-2022)
        1.5.1 China Bio-pharma Sales (K Pcs) and Growth Rate (%)(2012-2022)
        1.5.2 China Bio-pharma Revenue (Million USD) and Growth Rate (%)(2012-2022)

2 China Bio-pharma Market Competition by Players/Manufacturers
    2.1 China Bio-pharma Sales and Market Share of Key Players/Manufacturers (2012-2017)
    2.2 China Bio-pharma Revenue and Share by Players/Manufacturers (2012-2017)
    2.3 China Bio-pharma Average Price (USD/Pcs) by Players/Manufacturers (2012-2017)
    2.4 China Bio-pharma Market Competitive Situation and Trends
        2.4.1 China Bio-pharma Market Concentration Rate
        2.4.2 China Bio-pharma Market Share of Top 3 and Top 5 Players/Manufacturers
        2.4.3 Mergers & Acquisitions, Expansion in China Market
    2.5 China Players/Manufacturers Bio-pharma Manufacturing Base Distribution, Sales Area, Product Types

3 China Bio-pharma Sales and Revenue by Region (2012-2017)
    3.1 China Bio-pharma Sales (K Pcs) and Market Share by Region (2012-2017)
    3.2 China Bio-pharma Revenue (Million USD) and Market Share by Region (2012-2017)
    3.3 China Bio-pharma Price (USD/Pcs) by Regions (2012-2017)

4 China "&B1&" Sales and Revenue by Type/ Product Category (2012-2017)"
    4.1 China Bio-pharma Sales (K Pcs) and Market Share by Type/ Product Category (2012-2017)
    4.2 China Bio-pharma Revenue (Million USD) and Market Share by Type (2012-2017)
    4.3 China Bio-pharma Price (USD/Pcs) by Type (2012-2017)
    4.4 China Bio-pharma Sales Growth Rate (%) by Type (2012-2017)

5 China "&B1&" Sales by Application (2012-2017)"
    5.1 China Bio-pharma Sales (K Pcs) and Market Share by Application (2012-2017)
    5.2 China Bio-pharma Sales Growth Rate (%) by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6 China Bio-pharma Players/Suppliers Profiles and Sales Data
    6.1 Pfizer
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Bio-pharma Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Pfizer Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 F. Hoffmann-La Roche AG
        6.2.1 Company Basic Information, Manufacturing Base and Competitors
        6.2.2 Bio-pharma Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 F. Hoffmann-La Roche AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Johnson & Johnson Services
        6.3.1 Company Basic Information, Manufacturing Base and Competitors
        6.3.2 Bio-pharma Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Johnson & Johnson Services Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Sanofi, Amgen
        6.4.1 Company Basic Information, Manufacturing Base and Competitors
        6.4.2 Bio-pharma Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Sanofi, Amgen Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 AbbVie
        6.5.1 Company Basic Information, Manufacturing Base and Competitors
        6.5.2 Bio-pharma Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 AbbVie Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Merck & Co., Inc
        6.6.1 Company Basic Information, Manufacturing Base and Competitors
        6.6.2 Bio-pharma Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Merck & Co., Inc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Biogen Idec
        6.7.1 Company Basic Information, Manufacturing Base and Competitors
        6.7.2 Bio-pharma Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Biogen Idec Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Bayer AG
        6.8.1 Company Basic Information, Manufacturing Base and Competitors
        6.8.2 Bio-pharma Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Bayer AG Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Eli Lilly and Company
        6.9.1 Company Basic Information, Manufacturing Base and Competitors
        6.9.2 Bio-pharma Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Eli Lilly and Company Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Novartis AG GlaxoSmithKline Plc
        6.10.1 Company Basic Information, Manufacturing Base and Competitors
        6.10.2 Bio-pharma Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Novartis AG GlaxoSmithKline Plc Bio-pharma Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Bristol-Myers Squibb Company
    6.12 AstraZeneca PLC
    6.13 Abbott Laboratories

7 Bio-pharma Manufacturing Cost Analysis
    7.1 Bio-pharma Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Bio-pharma

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Bio-pharma Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Bio-pharma Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 China Bio-pharma Market Size (Sales and Revenue) Forecast (2017-2022)
    11.1 China Bio-pharma Sales (K Pcs), Revenue (Million USD) Forecast (2017-2022)
    11.2 China Bio-pharma Sales (K Pcs) Forecast by Type (2017-2022)
    11.3 China Bio-pharma Sales (K Pcs) Forecast by Application (2017-2022)
    11.4 China Bio-pharma Sales (K Pcs) Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Methodology and Data Source
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer
    13.4 Author List